Biology subjects

Blagih, J.

Publications and source records attributed to Blagih, J..

4 recordsLinked to original sources

bioRxiv2026

Fatty acid metabolism and dietary lipid composition shape B-cell responses

B-cell activation requires extensive metabolic reprogramming, yet how B cells acquire and utilize extracellular fatty acids and adapt to changes in lipid availability remains poorly understood. Here, we show that B-cell activation and the extracellular lipid environment dynamically regulate B cells. B-cell receptor (BCR) and Toll-like receptor 4 (TLR4) stimulation induced distinct mitochondrial and lipid-handling programs, differentially regulating fatty-acid uptake, cholesterol acquisition, lipid storage and mitochondrial respiration. Disrupting long-chain fatty-acid uptake, acyl-CoA activation, or mitochondrial utilisation impaired B-cell proliferation, demonstrating that multiple steps of fatty-acid metabolism are required for B-cell expansion. However, increasing extracellular fatty-acid availability alone did not enhance proliferation, indicating that fatty-acid acquisition and metabolic utilisation are functionally distinct. B cells also acquired fatty acids directly from adipocytes, identifying the local microenvironment as a potential source of metabolic substrates. In vivo, dietary fatty-acid chain length differentially shaped the germinal-centre response. A long-chain fatty-acid-rich diet increased germinal-centre B cells and T follicular helper cells and induced mitochondrial and transcriptional changes that partially converged with those observed following obesogenic feeding. Circulating lipidomics further revealed shared remodelling of lipid species between long-chain fatty-acid-rich and obesogenic diets, including altered partitioning of stearate-containing lipids. Exogenous fatty acids also modified membrane order in activated B cells, suggesting that lipid availability can influence both metabolic and biophysical properties. Together, these findings establish fatty-acid uptake, activation, and utilization as integral components of B-cell metabolic adaptation and demonstrate that dietary fatty-acid composition can remodel the lipid environment and germinal-centre response.

immunology↗

bioRxiv2026

Saturated fatty acid chain length shapes B cell lymphoma metabolism and progression

B-cell lymphomas reprogram cellular metabolism to sustain their rapid growth and proliferation. Despite their close proximity to adipose tissue and the paradoxical association between obesity and improved lymphoma outcomes, how fatty-acid availability and dietary fat composition influence B-cell lymphoma remains poorly understood. Importantly, saturated fatty acids of different chain lengths have distinct routes of cellular uptake and metabolic fates and may therefore exert divergent effects on tumour growth. Here, we investigated how medium-chain and long-chain saturated fatty acids, their dietary availability, and their transfer from adipocytes shape B-cell lymphoma metabolism and progression. We found that B-cell lymphoma cells were dependent on fatty-acid uptake, activation, and utilization for proliferation. Additionally, we identified adipocytes as microenvironmental players that transfer fatty acids and suppress cell growth. Interestingly, in most B-cell lymphomas, exogenous palmitate limits lymphoma cell proliferation, while MCFA caprylic acid showed only mild effects. Using a syngeneic B-cell lymphoma orthotopic model, we found that an MCFA-rich diet increased lymphoma burden and accelerated lymph-node progression, whereas LCFA-rich and obesogenic diets restricted lymphoma dissemination. Dietary fatty-acid composition also altered T-cell exhaustion and profoundly remodelled the circulating lipidome, with LCFA-rich and obesogenic diets producing highly concordant lipidomic signatures distinct from MCFA feeding. Across B-cell lymphoma cell lines, low ACSL1 expression was associated with increased palmitate sensitivity, which we computationally modelled as a targetable vulnerability in B-cell lymphoma treatment. Taken together, our results show that lipid metabolism is a metabolic vulnerability that can be targeted through dietary intervention.

cancer biology↗

bioRxiv2025

ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity

Chronic inflammation in autoimmunity is driven by T cell hyperactivation. This unregulated response to self is fuelled by heightened metabolic programmes, which offers a promising new direction to uncover novel treatment strategies. /{beta}-hydrolase domain-containing protein 11 (ABHD11) is a mitochondrial hydrolase that maintains the catalytic function of -ketoglutarate dehydrogenase (-KGDH), and its expression in CD4+ T cells has been linked to remission status in rheumatoid arthritis (RA). However, the importance of ABHD11 in regulating T cell metabolism and function - and thus, the downstream implication for autoimmunity - is yet to be explored. Here, we show that pharmacological inhibition of ABHD11 dampens cytokine production by human and mouse T cells. Mechanistically, the anti-inflammatory effects of ABHD11 inhibition are attributed to increased 24,25-epoxycholesterol (24,25-EC) biosynthesis and subsequent liver X receptor (LXR) activation, which arise from a compromised TCA cycle. The impaired cytokine profile established by ABHD11 inhibition is extended to two patient cohorts of autoimmunity. Importantly, using a murine model of accelerated type 1 diabetes (T1D), we show that targeting ABHD11 suppresses cytokine production in antigen-specific T cells and delays the onset of diabetes in vivo. Collectively, our work provides pre-clinical evidence that ABHD11 is an encouraging drug target in T cell-mediated autoimmunity. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/643996v1_ufig1.gif" ALT="Figure 1"> View larger version (59K): org.highwire.dtl.DTLVardef@bb3fcborg.highwire.dtl.DTLVardef@1594fc8org.highwire.dtl.DTLVardef@84e078org.highwire.dtl.DTLVardef@1ad023e_HPS_FORMAT_FIGEXP M_FIG C_FIG

immunology↗

bioRxiv2021

A non-canonical role for glutamate decarboxylase 1 in cancer cell amino acid homeostasis, independent of the GABA shunt.

Glutamate decarboxylase 1 (GAD1) is best known for its role in producing the neurotransmitter {gamma}-amino butyric acid (GABA) as part of the "GABA shunt" metabolic pathway, an alternative mechanism of glutamine anaplerosis for TCA cycle metabolism (Yogeeswari et al., 2005). However, understanding of the metabolic function of GAD1 in non-neuronal tissues has remained limited. Here, we show that GAD1 supports cancer cell proliferation independent of the GABA shunt. Despite its elevated expression in lung cancer tissue, GAD1 is not engaged in the GABA shunt in proliferating non-small cell lung cancer (NSCLC) cells, but rather is required for regulating amino acid homeostasis. Silencing GAD1 promotes a broad deficiency in amino acid uptake, leading to reduced glutamine-dependent TCA cycle metabolism and defects in serum- and amino acid-stimulated mTORC1 activation. Mechanistically, GAD1 regulates amino acid uptake through ATF4-dependent amino acid transporter expression including SLC7A5 (LAT1), an amino acid transporter required for branched chain amino acid (BCAA) uptake. Overexpression of LAT1 rescues the proliferative and mTORC1 signalling defects of GAD1-deficient tumor cells. Our results, therefore, define a non-canonical role for GAD1, independent of its characterised role in GABA metabolism, whereby GAD1 regulates amino acid homeostasis to maintain tumor cell proliferation.

cancer biology↗